Cargando…

A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer

IMPORTANCE: Treatment of resectable gastric cancer (RGC) uses a multimodal approach, including surgical treatment and chemotherapy with or without radiation therapy, and the optimal treatment strategy and timing of each of these modalities is unknown. OBJECTIVE: To investigate the association of var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, Eric, LeVee, Alexis, Kim, Sungjin, Atkins, Katelyn, Guan, Michelle, Placencio-Hickok, Veronica, Moshayedi, Natalie, Hendifar, Andrew, Osipov, Arsen, Gangi, Alexandra, Burch, Miguel, Waters, Kevin, Cho, May, Klempner, Samuel, Chao, Joseph, Kamrava, Mitchell, Gong, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665367/ https://www.ncbi.nlm.nih.gov/pubmed/34889947 http://dx.doi.org/10.1001/jamanetworkopen.2021.38432

Ejemplares similares

Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancer
por: Midthun, Lauren, et al.
Publicado: (2022)

Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy
por: Kim, Sungjin, et al.
Publicado: (2020)

Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers
por: Chuang, Jeremy, et al.
Publicado: (2022)

Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer
por: Muranaka, Hayato, et al.
Publicado: (2023)

Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers
por: David, John M., et al.
Publicado: (2018)

POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval
por: Bikhchandani, Mihir, et al.
Publicado: (2023)

Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations
por: Gong, Jun, et al.
Publicado: (2019)

The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies
por: Gong, Jun, et al.
Publicado: (2019)

Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2020)

Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient‐reported outcomes in pancreatic cancer cachexia
por: Gresham, Gillian, et al.
Publicado: (2021)

Circulating tumor DNA dynamics and response to immunotherapy in colorectal cancer
por: Gong, Jun, et al.
Publicado: (2022)

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2022)

Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2022)

Gut microbiome and pancreatic cancer cachexia: An evolving relationship
por: Hendifar, Andrew, et al.
Publicado: (2022)

A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer
por: Tuli, R., et al.
Publicado: (2019)

Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations
por: Lee, Patrick C., et al.
Publicado: (2021)

The Challenges of Treating Patients with Breast Cancer and Obesity
por: LeVee, Alexis, et al.
Publicado: (2023)

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study
por: Gong, Jun, et al.
Publicado: (2022)

Palliative Radiation Therapy for Bone Metastases in Neuroendocrine Neoplasms
por: Guan, Michelle, et al.
Publicado: (2019)

1444. Urine Screening Prior to Surgical Valve Replacement: Should It Be Performed?
por: LeVee, Alexis, et al.
Publicado: (2019)

Advances in Pancreatic Ductal Adenocarcinoma Treatment
por: Anderson, Eric M., et al.
Publicado: (2021)

Incidence and prognostic impact of HER2‐positivity loss after dual HER2‐directed neoadjuvant therapy for HER2+ breast cancer
por: LeVee, Alexis, et al.
Publicado: (2023)

Eosinophilic pneumonia: A rare manifestation of amiodarone toxicity diagnosed using traditional bronchoscopy
por: LeVee, Alexis, et al.
Publicado: (2019)

Dubin-Johnson Syndrome Presenting During Cardiac Transplantation Evaluation
por: LeVee, Alexis, et al.
Publicado: (2020)

Clinical Applications of Minimal Residual Disease Assessments by Tumor-Informed and Tumor-Uninformed Circulating Tumor DNA in Colorectal Cancer
por: Gong, Jun, et al.
Publicado: (2021)

Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma
por: Hendifar, Andrew, et al.
Publicado: (2016)

Pancreatic Cancer Incidence Trends by Race, Ethnicity, Age and Sex in the United States: A Population-Based Study, 2000–2018
por: Samaan, Jamil S., et al.
Publicado: (2023)

Which Imaging Modality Is Superior for Prediction of Response to Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer?
por: Atkins, Jordan J., et al.
Publicado: (2013)

Adjuvant and neoadjuvant therapies in melanoma
por: Lim, Kok Haw Jonathan, et al.
Publicado: (2020)

Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
por: McFerrin, Coleman, et al.
Publicado: (2020)

Combined morphologic and metabolic pipeline for Positron emission tomography/computed tomography based radiotherapy response evaluation in locally advanced pancreatic adenocarcinoma
por: Lao, Yi, et al.
Publicado: (2019)

Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma
por: Chen, Xing, et al.
Publicado: (2022)

Neoadjuvant and adjuvant therapy in esophageal cancer
por: Weiss, Jennifer A., et al.
Publicado: (2023)

Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape
por: Osipov, Arsen, et al.
Publicado: (2019)

Evaluation of Mobile Health Applications to Track Patient-Reported Outcomes for Oncology Patients: A Systematic Review
por: Lu, Diana J., et al.
Publicado: (2020)

Paid Parental Leave Policies Among U.S. News & World Report 2020-2021 Best Hospitals and Best Hospitals for Cancer
por: Lu, Diana J., et al.
Publicado: (2021)

Pancreatic cancer ‘mismatch’ in Lynch syndrome
por: Hendifar, Andrew E, et al.
Publicado: (2019)

Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy: A Systematic Literature Review
por: Macarulla, Teresa, et al.
Publicado: (2020)

Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors
por: Iwatsuki, Masaaki, et al.
Publicado: (2018)

Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
por: Akateh, Clifford, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m2hmjqfdtebadk4fmqqjqe966p